http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106267416-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3692 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
| filingDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106267416-B |
| titleOfInvention | AIDS therapeutic equipment |
| abstract | A kind of AIDS therapeutic equipment for medical domain, it is characterized in that the separator of preparation energy washed corpuscles and blood plasma, it prepares HIVgp120 and gp41 antibody and combines HIVgp120 the and gp41 antibody of goat-anti Ig, respectively with foreign gene transfection and hybridoma technology building not only retained archaeocyte characteristic again energy indeterminate growth CD4+T cell strain and hybridoma macrophage strain, it is formulated in agar gel after amplifying cells strain and clarifier is formed with high-biocompatibility material package, gel is set to form antibody titer from high to low from top to bottom and the layer distributed of agarose concentration from low to high, wherein with goat-anti Ig mating type and sequestered gp120 and gp41 antibody, CD4+T cell strain, the strain of hybridoma macrophage is fixed on agar gel absorption HIV and is used , made clarifier is applied in combination with separator and regulatory process, and extracorporeally circulating blood is divided into blood plasma and haemocyte by separator, and the purified device of blood plasma, which filters out, converges feedback with haemocyte after HIV. |
| priorityDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 337.